| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3827505 | Progrès en Urologie | 2008 | 5 Pages |
Abstract
This preliminary study showed the interest of PDE 5 inhibitors to decrease the cardiac risk factor ApoB/ApoA-1 ratio. Randomised controlled studies with longer follow-up are needed to confirm those results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
T. Roumeguère, K. Zouaoui Boudjeltia, C. Hauzeur, A. Ramal, C. Schulman, M. Vanhaeverbeek, J. Ducobu, E. Wespes,